Fidelis Insurance Holdings Limited increased its common share repurchase authorization to $400 million, up from the $200 million level in place as of August 2025. The board also raised the quarterly dividend to $0.15 per share, payable on March 27 2026 to shareholders of record on March 16.
The move follows a 2025 capital‑allocation cycle in which the company repurchased 15,184,976 shares for $261.4 million and distributed $52.3 million in dividends. Management said the new authorization gives it greater flexibility to deploy capital while the stock trades below book value, a discount it views as a compelling buying opportunity.
Fidelis’s Q3 2025 results— a combined ratio of 79.0% and net income of $130.5 million— underscore the company’s underwriting strength and support its continued return of capital. The dividend increase and expanded buyback program signal confidence in the firm’s balance sheet and a commitment to shareholder value.
The stock is trading near its 52‑week high of $20.12, and analysts project the company will be profitable in 2026 with earnings of $1.95 per share. While the valuation is high relative to peers, the company’s capital‑allocation strategy and strong underwriting performance provide a foundation for future growth.
"We are, first and foremost, strategic capital allocators, focused on identifying the most compelling opportunities and prioritizing initiatives that drive shareholder value creation," said CEO Dan Burrows. "Today's announced increase to our common share repurchase authorization provides us with additional flexibility to capitalize on the considerable discount between our current stock price and net book value."
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.